Accedi

The first-order absorption model for extravascular administration describes the rate at which a drug is absorbed and eliminated, following the principles of first-order kinetics. This model is vital as it provides a mathematical representation of drug behavior within the body. It also allows for the prediction and interpretation of drug absorption and elimination based on the rate of change in drug concentration over time. This model can be visualized as a plasma concentration-time profile comprising absorption, post-absorption, and elimination phases. Crucial pharmacokinetic parameters such as peak plasma concentration (Cmax) and the duration required to reach it (tmax) can be calculated using this model.

Methods like residuals or the Wagner-Nelson method can be employed to determine the absorption rate constant. If the extrapolated and residual lines intersect at the y-axis at time t = 0, then there is no lag in absorption. However, if the intersection occurs at a time greater than zero, this indicates a time lag. The time lag is defined as the time difference between drug administration and the beginning of the absorption process. It is denoted by the symbol t0 and represents the start of absorption.

An interesting phenomenon that may occur in the plasma concentration-time curve is the flip-flop phenomenon. This refers to an interchange in the meanings of the slopes representing absorption and elimination. During the flip-flop phenomenon, a longer duration of drug sampling might be necessary to avoid overestimating the fraction of drug absorbed.

Tags

One compartment ModelExtravascular AdministrationFirst order AbsorptionDrug AbsorptionPharmacokineticsPlasma Concentration time ProfilePeak Plasma Concentration CmaxTime To Reach Cmax tmaxAbsorption Rate ConstantResiduals MethodWagner Nelson MethodTime Lag t0Flip flop Phenomenon

Dal capitolo 7:

article

Now Playing

7.8 : One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model

Pharmacokinetic Models

144 Visualizzazioni

article

7.1 : Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Pharmacokinetic Models

53 Visualizzazioni

article

7.2 : Model Approaches for Pharmacokinetic Data: Compartment Models

Pharmacokinetic Models

50 Visualizzazioni

article

7.3 : One-Compartment Open Model for IV Bolus Administration: General Considerations

Pharmacokinetic Models

105 Visualizzazioni

article

7.4 : One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

Pharmacokinetic Models

95 Visualizzazioni

article

7.5 : One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Pharmacokinetic Models

35 Visualizzazioni

article

7.6 : One-Compartment Model: IV Infusion

Pharmacokinetic Models

108 Visualizzazioni

article

7.7 : One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model

Pharmacokinetic Models

37 Visualizzazioni

article

7.9 : One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

Pharmacokinetic Models

205 Visualizzazioni

article

7.10 : One-Compartment Open Model: Urinary Excretion Data and Determination of k

Pharmacokinetic Models

60 Visualizzazioni

article

7.11 : Multicompartment Models: Overview

Pharmacokinetic Models

51 Visualizzazioni

article

7.12 : Two-Compartment Open Model: Overview

Pharmacokinetic Models

73 Visualizzazioni

article

7.13 : Two-Compartment Open Model: IV Bolus Administration

Pharmacokinetic Models

179 Visualizzazioni

article

7.14 : Two-Compartment Open Model: IV Infusion

Pharmacokinetic Models

137 Visualizzazioni

article

7.15 : Two-Compartment Open Model: Extravascular Administration

Pharmacokinetic Models

103 Visualizzazioni

See More

JoVE Logo

Riservatezza

Condizioni di utilizzo

Politiche

Ricerca

Didattica

CHI SIAMO

Copyright © 2025 MyJoVE Corporation. Tutti i diritti riservati